Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
CALL
FedEx
FDX
$79.1B
| $33M | 0.02% |
133,200
+91,600
| +220% | +$21M |
|
1002
Asana
ASAN
$2.25B
| $33M | 0.02% |
1,496,042
+325,789
| +28% | +$6.53M |
|
1003
Woodward
WWD
$19.7B
| $33M | 0.02% |
277,193
+56,843
| +26% | +$6.02M |
|
1004
CALL
Tapestry
TPR
$26.4B
| $32.9M | 0.02% |
768,900
| – | – |
|
1005
Hudbay
HBM
$13.1B
| $32.9M | 0.02% |
6,851,890
+3,027,781
| +79% | +$14.8M |
|
1006
Equinor
EQNR
$101B
| $32.8M | 0.02% |
1,124,042
+130,218
| +13% | +$3.71M |
|
|
GTY
1007
Getty Realty Corp
GTY
$2.07B
| $32.7M | 0.02% |
967,953
-154,498
| -14% | -$5.25M |
|
1008
Park Hotels & Resorts
PK
$3.19B
| $32.7M | 0.02% |
2,553,279
+109,581
| +4% | +$1.4M |
|
1009
StepStone Group
STEP
$4.05B
| $32.6M | 0.02% |
1,315,800
+636,866
| +94% | +$14.6M |
|
1010
State Street SPDR S&P Biotech ETF
XBI
$11.5B
| $32.6M | 0.02% |
392,311
+273,269
| +230% | +$22.9M |
|
1011
PUT
Halliburton
HAL
$28.9B
| $32.6M | 0.02% |
989,200
+339,200
| +52% | +$10.7M |
|
1012
CALL
Ulta Beauty
ULTA
$23.2B
| $32.6M | 0.02% |
69,200
-30,300
| -30% | -$14.8M |
|
1013
Ollie's Bargain Outlet
OLLI
$4.62B
| $32.6M | 0.02% |
562,043
+100,373
| +22% | +$6.18M |
|
1014
Lam Research
LRCX
$388B
| $32.6M | 0.02% |
506,410
-246,360
| -33% | -$13.9M |
|
1015
CALL
Kraft Heinz
KHC
$30.4B
| $32.5M | 0.02% |
914,500
-644,600
| -41% | -$24.8M |
|
1016
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$137M
| $32.5M | 0.02% |
324,511
+249,802
| +334% | +$35.2M |
|
|
LNW
1017
DELISTED
Light & Wonder
LNW
| $32.4M | 0.02% |
471,621
+461,573
| +4,594% | +$28.7M |
|
1018
Bruker
BRKR
$8.68B
| $32.4M | 0.02% |
438,415
-577,954
| -57% | -$44.1M |
|
1019
ITT
ITT
$18.3B
| $32.3M | 0.02% |
346,322
-619,915
| -64% | -$52.1M |
|
|
IPG
1020
DELISTED
Interpublic Group of Companies
IPG
| $32.3M | 0.02% |
836,688
+541,416
| +183% | +$20.4M |
|
1021
Asbury Automotive
ABG
$3.79B
| $32.3M | 0.02% |
134,257
-18,337
| -12% | -$3.86M |
|
1022
CALL
State Street Materials Select Sector SPDR ETF
XLB
$8.88B
| $32.3M | 0.02% |
778,600
-63,600
| -8% | -$2.53M |
|
1023
CALL
ConocoPhillips
COP
$160B
| $32.1M | 0.02% |
309,800
-212,200
| -41% | -$21.8M |
|
1024
STAAR Surgical
STAA
$1.17B
| $32M | 0.02% |
608,896
+605,710
| +19,012% | +$36.9M |
|
1025
PUT
Prudential Financial
PRU
$42.3B
| $32M | 0.02% |
362,800
-134,200
| -27% | -$11.2M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.